We are live on ! Find out more
KIDS icon

OrthoPediatrics

122 hedge funds and large institutions have $467M invested in OrthoPediatrics in 2024 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 41 increasing their positions, 37 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

15,300% more call options, than puts

Call options by funds: $462K | Put options by funds: $3K

11% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 18

11% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 37

1% more funds holding

Funds holding: 121122 (+1)

1% more capital invested

Capital invested by funds: $464M → $467M (+$3.43M)

0.65% more ownership

Funds ownership: 67.51%68.16% (+0.65%)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
122
Holders Change
+1
Holders Change %
+0.83%
% of All Funds
1.76%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
20
Increased
41
Reduced
37
Closed
18
Calls
$462K
Puts
$3K
Net Calls
+$459K
Net Calls Change
+$841K
Name Holding Trade Value Shares
Change
Change in
Stake
California State Teachers Retirement System (CalSTRS)
51
California State Teachers Retirement System (CalSTRS)
California
$467K -$2.15K -70 -0.4%
Invesco
52
Invesco
Georgia
$464K -$7.54K -246 -2%
American Century Companies
53
American Century Companies
Missouri
$451K +$186K +6,059 +63%
Ameriprise
54
Ameriprise
Minnesota
$449K -$116K -3,798 -20%
AllianceBernstein
55
AllianceBernstein
Tennessee
$421K +$11.7K +380 +3%
TC
56
TwinBeech Capital
New York
$412K +$440K +14,339 New
UBS AM
57
UBS AM
Illinois
$397K +$424K +13,820 New
JP Morgan Chase
58
JP Morgan Chase
New York
$396K -$222K -7,240 -34%
RA
59
Royce & Associates
New York
$380K -$1.3M -42,403 -76%
OQS
60
Occudo Quantitative Strategies
Florida
$357K -$36.8K -1,200 -9%
Canada Life
61
Canada Life
Manitoba, Canada
$328K
UBS Group
62
UBS Group
Switzerland
$319K -$248K -8,085 -42%
Envestnet Asset Management
63
Envestnet Asset Management
Illinois
$287K +$51.9K +1,692 +20%
MIM
64
MetLife Investment Management
New Jersey
$287K +$32K +1,044 +12%
Two Sigma Investments
65
Two Sigma Investments
New York
$279K -$313K -10,198 -51%
ALC
66
Alexander Labrunerie & Co
Missouri
$264K
CF
67
Corebridge Financial
Texas
$253K +$270K +8,808 New
Creative Planning
68
Creative Planning
Kansas
$252K +$40.6K +1,324 +18%
Franklin Resources
69
Franklin Resources
California
$234K +$249K +8,135 New
Mirae Asset Global ETFs Holdings
70
Mirae Asset Global ETFs Holdings
Hong Kong
$234K +$249K +8,135 New
TPI
71
Trust Point Inc
Wisconsin
$223K +$9.87K +322 +4%
AQR Capital Management
72
AQR Capital Management
Connecticut
$223K +$238K +7,749 New
Wells Fargo
73
Wells Fargo
California
$207K +$60.3K +1,968 +38%
DM
74
Deerfield Management
New York
$203K +$217K +7,072 New
ITIM
75
Indiana Trust & Investment Management
Indiana
$195K

KIDS Hedge Fund Activity: Q2 2024 in Review

122 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in OrthoPediatrics (KIDS) for Q2 2024, worth a combined $467M — up 0.74% from $464M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new KIDS positions and 18 closed out — a net gain of 2 holders — while 41 added to existing stakes and 37 trimmed.

The largest buyer was Soleus Capital Management, opening a new position worth an estimated $9.49M. The largest seller was ExodusPoint Capital Management, exiting entirely with an estimated $6.77M sold.

  • 122 institutional investors held OrthoPediatrics (KIDS) as of Q2 2024, up from 121 in Q1 2024.
  • Funds reported $467M of OrthoPediatrics stock for Q2 2024, up 0.74% quarter-over-quarter.
  • 20 funds opened new OrthoPediatrics positions in Q2 2024 and 18 closed out, a net change of +2 holders.
  • The largest OrthoPediatrics buyer in Q2 2024 was Soleus Capital Management, an estimated $9.49M added.
  • The largest OrthoPediatrics seller in Q2 2024 was ExodusPoint Capital Management, an estimated $6.77M sold.

Based on aggregated 13F filings for Q2 2024.